[
    [
        {
            "time": "2021-02-16",
            "original_text": "Eli Lilly (LLY) Gains As Market Dips: What You Should Know",
            "features": {
                "keywords": [
                    "Eli Lilly",
                    "Gains",
                    "Market Dips"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "Eli Lilly (LLY) Gains As Market Dips: What You Should Know",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-02-16",
            "original_text": "Coronavirus Mutations: Why The Battle Against Covid Is Just Beginning",
            "features": {
                "keywords": [
                    "Coronavirus",
                    "Mutations",
                    "Covid"
                ],
                "sentiment_score": -0.7,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "Coronavirus Mutations: Why The Battle Against Covid Is Just Beginning",
                "Correlation": 4,
                "Sentiment": 3,
                "Importance": 7,
                "Impact": 5,
                "Duration": 8,
                "Entity_Density": 2,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-02-16",
            "original_text": "U.S. Government to Purchase Minimum of 100,000 Doses of Etesevimab and Bamlanivimab Neutralizing Antibody Therapy",
            "features": {
                "keywords": [
                    "U.S. Government",
                    "Purchase",
                    "Doses",
                    "Antibody Therapy"
                ],
                "sentiment_score": 0.8,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "U.S. Government to Purchase Minimum of 100,000 Doses of Etesevimab and Bamlanivimab Neutralizing Antibody Therapy",
                "Correlation": 8,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 6,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-02-16",
            "original_text": "Global COVID cases top 113 million as FDA committee meets to vote on J&J vaccine",
            "features": {
                "keywords": [
                    "Global COVID cases",
                    "FDA",
                    "J&J vaccine"
                ],
                "sentiment_score": -0.6,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "Global COVID cases top 113 million as FDA committee meets to vote on J&J vaccine",
                "Correlation": 3,
                "Sentiment": 4,
                "Importance": 6,
                "Impact": 4,
                "Duration": 6,
                "Entity_Density": 2,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-02-16",
            "original_text": "Eli Lilly Signs $210 Million Deal With U.S. for Covid-19 Antibody Therapy",
            "features": {
                "keywords": [
                    "Eli Lilly",
                    "Deal",
                    "Covid-19",
                    "Antibody Therapy"
                ],
                "sentiment_score": 0.9,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "Eli Lilly Signs $210 Million Deal With U.S. for Covid-19 Antibody Therapy",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 10,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-02-16",
            "original_text": "US Government Calls For Additional Eli Lilly COVID-19 Antibody Therapy",
            "features": {
                "keywords": [
                    "US Government",
                    "Calls",
                    "Additional",
                    "Eli Lilly",
                    "COVID-19"
                ],
                "sentiment_score": 0.8,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "US Government Calls For Additional Eli Lilly COVID-19 Antibody Therapy",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-02-16",
            "original_text": "What's Moving The Market Friday? US Stocks Near Flat, Euro, Asian Stocks Lower",
            "features": {
                "keywords": [
                    "Moving The Market",
                    "US Stocks",
                    "Flat",
                    "Euro",
                    "Asian Stocks"
                ],
                "sentiment_score": -0.4,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "global markets"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "What's Moving The Market Friday? US Stocks Near Flat, Euro, Asian Stocks Lower",
                "Correlation": 2,
                "Sentiment": 5,
                "Importance": 5,
                "Impact": 4,
                "Duration": 3,
                "Entity_Density": 1,
                "Market_Scope": 7,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-02-16",
            "original_text": "UPDATE 2-U.S. to buy at least 100,000 doses of Lilly's COVID-19 antibody therapy",
            "features": {
                "keywords": [
                    "U.S.",
                    "buy",
                    "doses",
                    "Lilly's",
                    "COVID-19",
                    "antibody therapy"
                ],
                "sentiment_score": 0.8,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "UPDATE 2-U.S. to buy at least 100,000 doses of Lilly's COVID-19 antibody therapy",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 9,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-02-16",
            "original_text": "Eli Lilly says U.S. government has agreed to buy at least 100,000 doses of its COVID antibody therapy",
            "features": {
                "keywords": [
                    "Eli Lilly",
                    "U.S. government",
                    "agreed",
                    "buy",
                    "COVID",
                    "antibody therapy"
                ],
                "sentiment_score": 0.8,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "Eli Lilly says U.S. government has agreed to buy at least 100,000 doses of its COVID antibody therapy",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-02-16",
            "original_text": "Lilly announces additional doses of neutralizing antibody therapy purchased by U.S. government to treat COVID-19",
            "features": {
                "keywords": [
                    "Lilly",
                    "announces",
                    "additional doses",
                    "neutralizing antibody therapy",
                    "U.S. government",
                    "COVID-19"
                ],
                "sentiment_score": 0.8,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "Lilly announces additional doses of neutralizing antibody therapy purchased by U.S. government to treat COVID-19",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        }
    ]
]